The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

被引：2070

作者：

O'Neill, Luke A. J. ^{[1
]}

Bowie, Andrew G. ^{[1
]}

机构：

[1] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland

来源：

NATURE REVIEWS IMMUNOLOGY | 2007年 / 7卷 / 05期

基金：

爱尔兰科学基金会;

关键词：

D O I：

10.1038/nri2079

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Signalling by Toll-like receptors (TLRs) involves five adaptor proteins known as MyD88, MAL, TRIF, TRAM and SARM. Recent insights have revealed additional functions for MyD88 apart from NF-kappa B activation, including activation of the transcription factors IRF1, IRF5 and IRF7, and also a role outside the TLRs in interferon-gamma signalling. Biochemical information on MAL and TRAM has shown that both act as bridging adaptors, with MAL recruiting MyD88 to TLR2 and TLR4, and TRAM recruiting TRIF to TLR4 to allow for IRF3 activation. Finally, the function of the fifth adaptor, SARM, has been revealed, which negatively regulates TRIF. These new insights allow for a detailed description of the function of the five TIR-domain-containing adaptors in the initiation of TLR signalling.

引用

页码：353 / 364

页数：12

共 115 条

[1] Plasmodium berghei infection in mice induces liver injury by an IL-12-and toll-like receptor/myeloid differentiation factor 88-dependent mechanism
Adachi, K
Tsutsui, H
Kashiwamura, S
Seki, E
Nakano, H
Takeuchi, O
Takeda, K
Okumura, K
Van Kaer, L
Okamura, H
Akira, S
Nakanishi, K
[J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (10) : 5928 - 5934
[2] Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
Adachi, O
Kawai, T
Takeda, K
Matsumoto, M
Tsutsui, H
Sakagami, M
Nakanishi, K
Akira, S
[J]. IMMUNITY, 1998, 9 (01) : 143 - 150
[3] Pathogen recognition and innate immunity
Akira, S
Uematsu, S
Takeuchi, O
[J]. CELL, 2006, 124 (04) : 783 - 801
[4] Inhibition of phosphoinositide 3-kinase enhances TRIF-dependent NF-κB activation and IFN-β synthesis downstream of Toll-like receptor 3 and 4
Aksoy, E
Vanden Berghe, W
Detienne, S
Amraoui, Z
Fitzgerald, KA
Haegeman, G
Goldman, M
Willems, F
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (07) : 2200 - 2209
[5] SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production
An, Huazhang
Zhao, Wei
Hou, Jin
Zhang, Yan
Xie, Yun
Zheng, Yuejuan
Xu, Hongmei
Qian, Cheng
Zhou, Jun
Yu, Yizhi
Liu, Shuxun
Feng, Gensheng
Cao, Xuetao
[J]. IMMUNITY, 2006, 25 (06) : 919 - 928
[6] A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses
Bartfai, T
Behrens, MM
Gaidarova, S
Pemberton, J
Shivanyuk, A
Rebek, J
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7971 - 7976
[7] The dsRNA binding site of human toll-like receptor 3
Bell, Jessica K.
Askins, Janine
Hall, Pamela R.
Davies, David R.
Segal, David M.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (23) : 8792 - 8797
[8] The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses
Boone, DL
Turer, EE
Lee, EG
Ahmad, RC
Wheeler, MT
Tsui, C
Hurley, P
Chien, M
Chai, S
Hitotsumatsu, O
McNally, E
Pickart, C
Ma, A
[J]. NATURE IMMUNOLOGY, 2004, 5 (10) : 1052 - 1060
[9] ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance
Brint, EK
Xu, DM
Liu, HY
Dunne, A
McKenzie, ANJ
O'Neill, LAJ
Liew, FY
[J]. NATURE IMMUNOLOGY, 2004, 5 (04) : 373 - 379
[10] Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
Burns, K
Janssens, S
Brissoni, B
Olivos, N
Beyaert, R
Tschopp, J
[J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 263 - 268

← 1 2 3 4 5 6 7 8 9 10 →